Published in Int J Artif Organs on November 01, 1997
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med (1994) 2.53
Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest (1994) 2.47
Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J Biol Chem (2001) 2.25
Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med (1994) 2.01
Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity. Clin Exp Immunol (1980) 1.88
Expression and localization of HrpA1, a protein of Xanthomonas campestris pv. vesicatoria essential for pathogenicity and induction ofthe hypersensitive reaction. J Bacteriol (1996) 1.74
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med (2000) 1.62
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Increased resting energy expenditure is related to plasma TNF-alpha concentration in stable COPD patients. Clin Nutr (1999) 1.52
Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol (1991) 1.46
Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41
NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med (2000) 1.41
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol (1994) 1.39
[Stromal tumors in the digestive tract. A case of duodenal localization]. Presse Med (1998) 1.38
Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun (1994) 1.37
Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J (1999) 1.27
N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem (2001) 1.26
Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin. Mol Immunol (1986) 1.24
Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med (1993) 1.22
The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol (1982) 1.19
Ischaemic stroke subtypes and associated risk factors: a French population based study. J Neurol Neurosurg Psychiatry (2008) 1.18
Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol (1986) 1.15
Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. J Immunol (1982) 1.12
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res (1997) 1.12
Interleukin 1 secretion by human monocytes stimulated by the isolated polysaccharide region of the Bordetella pertussis endotoxin. Mol Immunol (1984) 1.11
C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol (1987) 1.10
Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun (2000) 1.10
Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun (1999) 1.08
Surface markers and electron microscopy of human blood L cells: a comparison with T and B lymphocytes. J Immunol (1978) 1.08
Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J Immunol Methods (1995) 1.07
Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis (1999) 1.07
Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke (1989) 1.05
Idiotypic determinants of rabbit B- and T-derived lymphocytes. Immunol Rev (1977) 1.04
Hrp Mutants of Pseudomonas solanacearum as Potential Biocontrol Agents of Tomato Bacterial Wilt. Appl Environ Microbiol (1994) 1.04
Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12. J Infect Dis (1999) 1.03
In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectins. Thromb Res (1979) 1.01
Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice. Mol Med (1997) 1.01
Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood (1998) 0.99
Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes. Eur J Immunol (1989) 0.99
Immunological and electrophoretic studies of human tear proteins. Exp Eye Res (1979) 0.98
Specific binding of endotoxin to human monocytes and mouse macrophages: serum requirement. Cell Immunol (1985) 0.98
Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia. Clin Nephrol (2007) 0.98
Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immun (1997) 0.98
Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage. Eur J Immunol (1997) 0.97
Immunopathology of the bronchial mucosa in 'late onset' asthma. Clin Allergy (1977) 0.97
Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide. Ann N Y Acad Sci (1994) 0.95
Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus. J Infect Dis (2000) 0.95
Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A. Infect Immun (2001) 0.94
Flavonoid-inducible modifications to rhamnan O antigens are necessary for Rhizobium sp. strain NGR234-legume symbioses. J Bacteriol (2006) 0.94
Combined idiopathic retroperitoneal and mediastinal fibrosis with pericardial involvement. Clin Nephrol (1999) 0.93
Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol (1995) 0.92
IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Cytokine (1996) 0.92
Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. J Pharmacol Exp Ther (2004) 0.91
Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006. Neurology (2009) 0.90
Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant (1998) 0.90
Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFbeta)of interleukin-8 production by LPS- and/ or TNFalpha-activated human polymorphonuclear cells. Mediators Inflamm (1996) 0.90
In vivo induction of interleukin-1 during hemodialysis. Kidney Int (1989) 0.89
Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A. Immunol Lett (1982) 0.89
Inability of pyrogenic, purified Bordetella pertussis lipid A to induce interleukin-1 release by human monocytes. Infect Immun (1986) 0.89
High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine (1993) 0.89
Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures. Shock (2000) 0.88
A sensitive, IL-2-independent, assay for IL-1. J Immunol Methods (1988) 0.88
Selective cytotoxicity of Clostridium perfringens delta toxin on rabbit leukocytes. Infect Immun (1982) 0.88
Polyclonal antibody-forming cell activation and immunomodulation of the in vitro immune response induced by streptococcal extracellular products. Cell Immunol (1983) 0.87
Elevated levels of circulating transforming growth factor-beta 1 in patients with the sepsis syndrome. Ann Intern Med (1996) 0.87
Patients admitted to emergency services for drunkenness: moderate alcohol users or harmful drinkers? Am J Psychiatry (2001) 0.87
Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine (1992) 0.87
Effect of intracellular iron loading on lipid peroxidation of brain slices. Free Radic Biol Med (1996) 0.86
Effect of diets with different magnesium content in ischemic stroke rats. Neurosci Lett (2004) 0.86
Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin. J Leukoc Biol (1986) 0.86
Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol (2001) 0.86
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure. Am J Transplant (2014) 0.85
Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med (1997) 0.85
Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes. Immunobiology (1992) 0.85
Induction of interferon by streptococcus pyogenes extracellular products. Immunol Lett (1982) 0.85
Interleukin-1 induction by lipopolysaccharides: structural requirements of the 3-deoxy-D-manno-2-octulosonic acid (KDO). Mol Immunol (1989) 0.85
Lipopolysaccharide-induced production of cytokines by bone marrow-derived macrophages: dissociation between intracellular interleukin 1 production and interleukin 1 release. Cytokine (1990) 0.85
Dialysis and central venous catheter infections in critically ill patients: results of a prospective study. Crit Care Med (1999) 0.85
The production of TNF alpha and IL-8 in whole blood assays are differently regulated upon activation by LPS. Prog Clin Biol Res (1995) 0.85
Interleukin 8 production in whole blood assays: Is interleukin 10 responsible for the downregulation observed in sepsis? Cytokine (2000) 0.85
Involvement of the LPS receptor in the induction of interleukin-1 in human monocytes stimulated with endotoxins. Ann Inst Pasteur Immunol (1987) 0.83
Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species. Immunobiology (1994) 0.83
Rabbit B spleen lymphocytes and T helper cells. I. Responsiveness to mitogens of B cell subpopulations of different sedimentation velocities and subpopulations bearing or lacking Fcgamma receptors. J Immunol (1979) 0.83
Differential MnSOD and HO-1 expression in cerebral endothelial cells in response to sublethal oxidative stress. Brain Res (2004) 0.83
Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study. Am J Transplant (2012) 0.83
Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clin Nephrol (2011) 0.83
Elevated serum beta 2-microglobulin levels and C1q-binding immune complexes in sarcoidosis. Biomedicine (1979) 0.83
Effect of early decrease in the lesion size on late brain tissue loss, synaptophysin expression and functionality after a focal brain lesion in rats. Neurochem Int (2006) 0.83
Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect (2000) 0.83
Early enterocytic differentiation of HT-29 cells: biochemical changes and strength increases of adherens junctions. Exp Cell Res (2004) 0.82
Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. J Infect Dis (1994) 0.82
Ipsilateral versus contralateral spontaneous post-stroke neuroplastic changes: involvement of BDNF? Neuroscience (2012) 0.82
Increased serum levels of interleukin 10 in Sjögren's syndrome; correlation with increased IgG1. J Rheumatol (2000) 0.82
Inhibition by gangliosides of the specific binding of lipopolysaccharide (LPS) to human monocytes prevents LPS-induced interleukin-1 production. Cell Immunol (1987) 0.82
[Epiphyseal pain from cyclosporine in renal transplants]. Nephrologie (1997) 0.82
Paradoxical priming effects of IL-10 on cytokine production. Int Immunol (1999) 0.81